PepGen Inc. PEPG
Updated: 10 Aug 2026
No signal published yet
We already track PepGen and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.
Email when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
Temporary check — not Firelda's published signal.
General analysis — not personal advice.
Want to follow PepGen Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.
Follow PepGen free Follow freeEmail when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
Recent News
On August 6, 2026, PepGen reported its second-quarter 2026 financial results and announced that an independent monitoring board recommended dose escalation for PGN-EDODM1 in its Phase 2 FREEDOM2 trial. The company ended June 2026 with $117.2 million in cash and marketable securities, which it expects to fund operations into the fourth quarter of 2027.
What Firelda Watch includes for PepGen Inc.
Add the company to your watchlist and get all of this automatically.
- Free: 3 companies on your watchlist
- Change history and monitoring for every company you follow
- Sunday weekly brief — a short weekly roundup
- Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
Want to follow PepGen Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.
Follow PepGen free Follow freeEmail when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more